biotechtrader
There's no doubt that Bisantrene showed a lot of promise with AML and hopefully those results can be replicated (improved on?). Some concern over toxicity - quite a few years have passed, FDA standards might have changed. I'm just playing Devil's advocate, but the submission to the FDA was quite some time ago and we don't don't know whether RAC has addressed the FDA's questions yet. They've gone quiet on this one and I didn't get a reply when I enquired about whether RAC was still working on their reply.
Cheers
30 cent target, page-13
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.050(3.13%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.70 | $1.52 | $318.0K | 193.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 496 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 5484 | 2 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |